Kevin Fischbeck
Stock Analyst at B of A Securities
(4.05)
# 508
Out of 4,876 analysts
165
Total ratings
66.39%
Success rate
5.65%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Neutral | $320 → $260 | $239.90 | +8.38% | 15 | Jun 17, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $165 → $180 | $172.56 | +4.31% | 5 | May 14, 2025 | |
| UNH UnitedHealth Group | Downgrades: Neutral | $560 → $350 | $302.62 | +15.66% | 22 | May 14, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Buy | $50 → $45 | $22.06 | +101.77% | 6 | Feb 28, 2025 | |
| HCA HCA Healthcare | Maintains: Buy | $380 → $370 | $377.66 | -2.03% | 9 | Jan 27, 2025 | |
| ARDT Ardent Health | Downgrades: Neutral | $22 → $19 | $13.31 | +42.75% | 2 | Nov 6, 2024 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $21.04 | +128.14% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $2.31 | +29.87% | 2 | Oct 2, 2024 | |
| DVA DaVita | Maintains: Underperform | $139 → $145 | $141.09 | +2.77% | 12 | Aug 7, 2024 | |
| ELV Elevance Health | Downgrades: Neutral | $646 → $530 | $373.18 | +42.02% | 3 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $291.06 | +50.83% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $9.42 | -31.00% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $13.76 | -47.31% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $79 → $72 | $53.57 | +34.40% | 11 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $330.00 | +6.06% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $183 | $177.43 | +3.14% | 14 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $21.70 | +107.37% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $121.54 | -39.11% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.48 | +58.05% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $15.01 | +133.18% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.79 | +258.42% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $13.11 | -42.79% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $32.00 | -43.75% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $13.63 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $28.50 | -33.33% | 2 | Feb 9, 2018 |
Humana
Jun 17, 2025
Maintains: Neutral
Price Target: $320 → $260
Current: $239.90
Upside: +8.38%
Tenet Healthcare
May 14, 2025
Maintains: Buy
Price Target: $165 → $180
Current: $172.56
Upside: +4.31%
UnitedHealth Group
May 14, 2025
Downgrades: Neutral
Price Target: $560 → $350
Current: $302.62
Upside: +15.66%
Acadia Healthcare Company
Feb 28, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $22.06
Upside: +101.77%
HCA Healthcare
Jan 27, 2025
Maintains: Buy
Price Target: $380 → $370
Current: $377.66
Upside: -2.03%
Ardent Health
Nov 6, 2024
Downgrades: Neutral
Price Target: $22 → $19
Current: $13.31
Upside: +42.75%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $21.04
Upside: +128.14%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $2.31
Upside: +29.87%
DaVita
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $141.09
Upside: +2.77%
Elevance Health
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $373.18
Upside: +42.02%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $291.06
Upside: +50.83%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.42
Upside: -31.00%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $13.76
Upside: -47.31%
Sep 5, 2023
Upgrades: Neutral
Price Target: $79 → $72
Current: $53.57
Upside: +34.40%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $330.00
Upside: +6.06%
Jul 27, 2023
Maintains: Buy
Price Target: $183
Current: $177.43
Upside: +3.14%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $21.70
Upside: +107.37%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $121.54
Upside: -39.11%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.48
Upside: +58.05%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $15.01
Upside: +133.18%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.79
Upside: +258.42%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $13.11
Upside: -42.79%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $32.00
Upside: -43.75%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $13.63
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $28.50
Upside: -33.33%